Hasil Pencarian - Kuo-Hung Lin

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Automatic capture management may cause unnecessary battery depletion in selective his‐bundle pacing

    Automatic capture management may cause unnecessary battery depletion in selective his‐bundle pacing oleh Hung‐Pin Wu, Jan‐Yow Chen, Kuo‐Hung Lin, Kuan‐Cheng Chang

    Diterbitkan 2020-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Promoter polymorphism G-6A, which modulates angiotensinogen gene expression, is associated with non-familial sick sinus syndrome.

    Promoter polymorphism G-6A, which modulates angiotensinogen gene expression, is associated with non-familial sick sinus syndrome. oleh Jan-Yow Chen, Ying-Ming Liou, Hong-Dar Isaac Wu, Kuo-Hung Lin, Kuan-Cheng Chang

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial.

    Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial. oleh Reece Holbrook, Lucas Higuera, Kael Wherry, Dave Phay, Yu-Cheng Hsieh, Kuo-Hung Lin, Yen-Bin Liu

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Transforming Growth Factor-β1 T869C Gene Polymorphism Is Associated with Acquired Sick Sinus Syndrome via Linking a Higher Serum Protein Level.

    Transforming Growth Factor-β1 T869C Gene Polymorphism Is Associated with Acquired Sick Sinus Syndrome via Linking a Higher Serum Protein Level. oleh Jan-Yow Chen, Jiung-Hsiun Liu, Hong-Dar Isaac Wu, Kuo-Hung Lin, Kuan-Cheng Chang, Ying-Ming Liou

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study

    Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study oleh Balbir Singh, Yu-Cheng Hsieh, Yen-Bin Liu, Kuo-Hung Lin, Boyoung Joung, Diego A. Rodriguez, Alexandr R. Chasnoits, Dejia Huang, Shu Zhang, Janet E. O'Brien, Daniel R. Lexcen, Jeffrey Cerkvenik, Brian Van Dorn, Chi-Keong Ching

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: